KaydedilenlerDerginizi ekleyin

Dergiler / Journal of Clinical and Experimental Investigations / 2026 / Cilt: 7 Sayı: 3

Failure of Therapy at Premortem Diagnosed Pulmonary Thromboembolism

Aysun Yakar
Fatih Yakar
Sibel Çağlar Atacan
Muhlis Yıldız
İbrahim Üzün
Sayfa
237–243
Yayın Tarihi
2016-09-01
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

If risk factors are present for a prolonged period, or if new risk factors for PTE are identified, patients should be followed up carefully because of the risk of progression of thrombosis.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objectives: We analyzed patients diagnosed premortem with pulmonary thromboembolism (PTE), focusing on causes of failure of therapy together with clinical characteristics.
📊
Temel Bulgular & Veri:Methods: This was a retrospective study of 25 cases.
💡
Sonuç & Katkı:If risk factors are present for a prolonged period, or if new risk factors for PTE are identified, patients should be followed up carefully because of the risk of progression of thrombosis.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Causes · Failure of Treatment · PTE

Abstract

Objectives: We analyzed patients diagnosed premortem with pulmonary thromboembolism (PTE), focusing on causes of failure of therapy together with clinical characteristics. Methods: This was a retrospective study of 25 cases. We classified PTE as massive, submassive and nonmassive. Results: Of the 25 cases, 76% (19/25) had two or more risk factors for PTE. The point of origin of PE could be determined in only 44% of 25 cases. In 20 % (5/25) of cases diagnosed with PTE a maximum 3 months prior to death, the main cause of death was unknown. Of 10/20 (50%) massive and 8/20 (40%) submassive PTE cases, 5 and 3 underwent thrombolysis therapy, respectively. Both of 2/20 (10%) non-massive PTE cases underwent LMWH; in 1 of these cases, autopsy showed thrombus of a large pulmonary artery at 25 days after therapy. Submassive PTE cases were older and had a greater number of risk factors than did massive PTE cases. The point of origin of PTE was a right heart thrombus in six (24%) cases. Surgeries were performed in 3/6 (50 %) cases with right atrial thrombus. The survival duration after therapy in those who underwent surgery was longer than those who received thrombolysis and LMWH therapies. Conclusions: Physicians may provide appropriate information to patients who have certain risk factors (trauma, surgery, pregnancy, etc.) to predict acute PE at a preventable stage. If risk factors are present for a prolonged period, or if new risk factors for PTE are identified, patients should be followed up carefully because of the risk of progression of thrombosis.

🔖

Bu Makaleye Atıf Yap

Yakar, A., Yakar, F., Atacan, S. Ç., Yıldız, M., Üzün, İ. (2016). Failure of Therapy at Premortem Diagnosed Pulmonary Thromboembolism. Journal of Clinical and Experimental Investigations, Cilt: 7 Sayı: 3, 237–243. https://doi.org/10.5799/jcei.328615

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (28)

  1. Konstantinides SV, Torbicki A, Agnelli G, et al. 2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism. European Heart J 2014; 35:3033-3080.
  2. Kürkciyan I, Meron H, Sterz F, et al. Pulmonary embolism as cause of cardiac arrest. Arch Intern Med 2000; 160:1529-1535.
  3. Böttiger BW, Böhner H, Bach A, et al. Bolus injection of thrombolytic agents during cardiopulmonary resuscitation for massive pulmonary embolism. Resuscitation 1994; 28:45-54.
  4. Konstantinides SV, Geibel A, Heusel G, et al. Heparin plus Alteplase compared with heparin alone in patients with submassive pulmonary embolism. N Engl J Med 2002; 347:1143-50.
  5. Agnelli G, Becattini C, Kirschstein T. Thrombolysis vs. heparin in the treatment of pulmonary embolism. Clinical outcome based meta-analysis. Arch Intern Med 2002; 162:2537-2541.
  6. Meneveau N, Séronde MF, Blonde MC, et al. Management of Unsuccessful Thrombolysis in Acute Massive Pulmonary Embolism. Chest 2006;129:1043–1050.
  7. Wood KE. Major Pulmonary Embolism. Crit Care Clin 2011;27:885-906.
  8. Saad N. Aggressive Management of Pulmonary Embolism. Semin Intervent Radiol 2012; 29:52-56.
  9. Bensaid Y, Ameur A, Kabiri H, et al. Arterial complications of Behcet’s disease. Report of 13 cases. J Mal Vasc 1997; 22:24-28.
  10. Marik PE, Plante L.A. Venous Thromboembolic Disease and Pregnancy. N Engl J Med 2008;359:2025-33.
  11. Wartman WB, Hellerstein HK. The incidence of heart disease in 2000 consecutive autopsies. Ann Intern Med 1948; 28:41-65.
  12. Kinney EL, Wright RJ. Efficacy of treatment of patients with echocardiographically detected rightsided heart thrombi-a meta analysis. Curriculum in Cardiology, Feb. 9,1989.
  13. European Working Group on Echocardiography and pulmonary embolism. Ann Intern Med 1977;7:720-721.
  14. Farfel Z, Shechter M, Vered Z, et al. Review of echocardiographically diagnosed right heart entrapment of pulmonary emboli in transit with emphasis on management. Am Heart J 1987;113:171-178.
  15. Panidis IP, Kotler MN, Mintz GS, et al. Clinical and echocardiographic features of right atrial masses. Am Heart J 1984;107:745-758.
  16. Rose PS, Punjabi NM, Pearse DB. Treatment of right heart thromboemboli. Chest 2002; 121:806-814.
  17. Pierre-Justin G, Pierard LA. Management of mobile right hearts thrombi: A prospective series. Int J Cardiol 2005; 99:381-388. 18. Mohan B, Chhabra ST, Gulati A, et al. Clinical and echocardiographic diagnosis, follow up and management of right sided cardiac thrombi. Indian Heart J 2013; 65:529-535.
  18. Torbicki A, Galie N, Covezzoli A, et al. Right Heart Thrombi in Pulmonary Embolism. Results from the International Cooperative Pulmonary Embolism Registry. Journal of the American College of Cardiology 2003;41:2245-2251.
  19. Sahin M, Arslan C, Tunc SE, et al. A fatal case of Behçet’s disease with rare complications. Saudi Med J 2006; 27 (11):1754–1757.
  20. Kale A, Akyıldız L, Akdeniz N, et al. Pregnancy complicated by superior vena cava thrombosis and pulmonary embolism in a patient with Behçet’s disease and the use of heparin for treatment. Saudi Med J 2006;27(1):95-97.
  21. Saghil G, Doghmil N. Intracardiac thrombosis in Behçet’s disease: a rare complication. Pan Afr Med J 2013;15:91. 23. Marc K, Iraqui G, Jniene A, et al. [Intracardiac thrombus and pulmonary artery aneurysm in Behçet’s disease]. Rev Mal Respir, 2008; 25(1):69-72.
  22. Xing W, Swaminathan G, Appadorai DR, et al. Rare Case of Behçet’s Disease Presenting with Pyrexia of Unknown Origin, Pulmonary Embolism, and Right Ventricular Thrombus. Int J Angiol, 2013;22:193-198.
  23. Chang JE, Lee YH, Lee J. Multiple cardiovascular complications in a patient with Behcet’s disease. Korean J Intern Med 2008; 23 (2):100–102.
  24. San Luis Miranda R, Lázaro Castillo JL, Enciso Gómez R, et al. [Right ventricular thrombus and pulmonary artery aneurysms in Behçet’s disease. Report of one case]. Arch Cardiol Mex, 2007;77(2):130–136.
  25. Desbois AC, Wechsler B, Resche-Rigon M, et al. Immunosuppressants reduce venous thrombosis relapse in Behçet's disease.Arthritis Rheum 2012;64:2753-60.
  26. Hammami R, Abid L, Frikha F, et al. Intracardiac Thrombus in a Young Man: Don’t Forget Behçet’s Disease. Intern Med 2012; 51:1865-1867.
  27. Dogan SM, Birdane A, Korkmaz C, et al. Right ventricular thrombus with Behçet’s syndrome: successful treatment with warfarin and immunosuppressive agents. Tex Heart Inst J 2007;34:360-362.
  28. Stein PD, Goodman LR, Hull RD, et al. Diagnosis and management of isolated subsegmental pulmonary embolism; review and assessment of the options. Clin Appl Thromb Hemost 2012;18:20-26.